Live·Open questions in longevity research
Back to Eternal Search
Johnson & Johnson

Johnson & Johnson

corporateWebsite
field
Medicine
sub field
BiotechDrug Discovery
approach
Translational
resource type
Residency
stage
Startup
geography
Asia-PacificGlobal

Fund rating

0.0 / 35
0 published reviews
No per-dimension scores yet.

Published reviews

About

Evidence shows Johnson & Johnson in a strategic collaboration with BigHat Biosciences. For OpenDrugs, this makes J&J a credible strategic partner target for research, data, or downstream pharma collaboration around aging-related compounds and evidence-backed substance intelligence.